Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 294)
Posted On: 07/31/2019 7:31:45 AM
Post# of 153930
Posted By: Fortuno
Re: misiu143 #5570
But is 95% efficacy correct to use if it only takes responders into account?
I don’t feel that’s right.

Lalezari also said: “as mono, good, as combination, better” or words alike.
Obviosly he thinks efficacy will be better if combined.

Question will be where Leronlimab to combine with?
Dr. Lalezari said there is a variety of new HIV-treatments that has partner potential.
What could he be talking about?














(1)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site